InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-20.9%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Rich Stuart, Directeur Médical. Director active across 1 company, notably Tenax Therapeutics, INC.. Cumulatively, 4 reports have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €8k. Activity tracked since 12 October 2021. The latest transaction was disclosed on 2 December 2025 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Declarations4 total
1,000 shares@ US$9.0059Common StockSEC:0001841785-25-000003:0
Ideal exit: 29 Aug 2026 (T+270)
1,909,585 shares0Common StockSEC:0001654954-22-012922:0
1,909,585 shares0Common StockSEC:0001654954-21-012861:0
3,581,000 sharesCommon StockSEC:0001654954-21-006927:0
4 of 4 declarations
About Rich Stuart
Rich Stuart is the Chief Medical Officer of TENAX THERAPEUTICS, INC. He is responsible for leading the company's medical and clinical initiatives. His role is essential for the development of new treatments and ensuring compliance with medical regulations. Rich brings significant expertise in the medical field, contributing to the mission of TENAX THERAPEUTICS, INC.
